Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
Launched by ROYAL MARSDEN NHS FOUNDATION TRUST · Dec 18, 2009
Trial Information
Current as of June 22, 2025
Unknown status
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged \> 18
- • Informed written consent
- • Histological confirmation of adenocarcinoma of rectum
- • Undergoing pre-operative radiotherapy/ chemotherapy
- • Completion of pre-operative treatment
- Exclusion Criteria:
- • Aged \< 18
- • Absence of pre-operative RT/CT
- • Medical/ psychiatric conditions that compromise the patients ability to give informed consent
- • Contra-indications to MRI, i.e. hip prothesis, cardiac pacemaker
About Royal Marsden Nhs Foundation Trust
The Royal Marsden NHS Foundation Trust is a leading cancer treatment and research institution in the UK, renowned for its commitment to advancing oncology through innovative clinical trials and cutting-edge therapies. With a multidisciplinary team of experts, the Trust integrates patient care with groundbreaking research, fostering a collaborative environment to improve outcomes for cancer patients. As a pioneer in the field, the Royal Marsden actively contributes to the development of new treatment protocols and plays a critical role in translating scientific discoveries into clinical practice, ensuring that patients have access to the latest advancements in cancer care.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Montreal, Quebec, Canada
Nicosia, , Cyprus
London, , United Kingdom
Sao Paulo, , Brazil
Huntingdon, Cambridgeshire, United Kingdom
Durham, County Durham, United Kingdom
Stockton On Tees, County Durham, United Kingdom
Dorchester, Dorset, United Kingdom
Poole, Dorset, United Kingdom
Colchester, Essex, United Kingdom
Portsmouth, Hampshire, United Kingdom
Gillingham, Kent, United Kingdom
Harrow, Middlesex, United Kingdom
Great Yarmouth, Norfolk, United Kingdom
Carshalton, Surrey, United Kingdom
Chichester, West Sussex, United Kingdom
Wakefield, West Yorkshire, United Kingdom
Bath, , United Kingdom
Birmingham, , United Kingdom
Croydon, , United Kingdom
Manchester, , United Kingdom
Sutton, , United Kingdom
Patients applied
Trial Officials
Diana Tait
Principal Investigator
Royal Marsden NHS Foundation Trust
Gina Brown
Principal Investigator
Royal Marsden Hospitals NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials